Jecho Laboratories, Inc. will be presenting on Monday, March 2 at 4:30 p.m. in the ERC Ballroom. Jecho is a clinical-stage drug discovery company developing innovative biologics, including antibodies, ...

Kerna Ventures is an early-stage, academia-rooted, geo-agnostic VC firm investing seed through Series A in advanced therapeutic platform technologies in genetic medicine, targeted delivery and advance ...

Kernal Bio is VC-backed biotech company pioneering mRNA 2.0 immunotherapies. We leverage selective mRNA-LNP technology to treat cancer and autoimmune diseases with precision, ensuring targeted deliver ...

Kesmalea is developing orally available, CNS penetrant targeted protein degraders. We are backed by Syncona and OSE. Kesmalea’s SELFTAC® platform is a widely applicable solution to the “size problem” ...

Khosla Ventures invests in companies that are bold, early and impactful. The firm was started in 2004 by Vinod Khosla, co-founder of Sun Microsystems, to provide venture assistance to entrepreneurs. H ...

The Next Trillion DollarRevolution Isn’t Digital.... It’s Biological, And It Starts With Real-Time Human ISF Access​KIFFIK Biomedical is pioneering interstitial fluid (ISF)-based diagnostics, transfor ...

KYAN Technologies is leading the way in functional precision medicine and tackling the complexity of cancer by integrating small data AI and ex-vivo biological experiments.

Lactiga is an emerging biotechnology company pioneering the development of first-in-class mucosal immunotherapies. Our lead asset, LCTG-001, is a secretory IgA (sIgA) nasal spray therapy sourced from ...

(PLEASE NO SERVICES) Lahjavida (La-Ya-Vida) is pioneering a novel class of small-molecule Dye Drug Conjugates (DDCs) designed to improve cancer treatment by delivering potent cytotoxic agents directly ...

Lake Street is a boutique investment bank focused on emerging growth companies in Biotech and MedTech. We are full service, offering sell-side equity research, capital raising, and M&A and strategic a ...